Publications: Ms Giulia Vivaldi

Hajmohammadi H, Talaei M, Fecht D, Wang W, Vivaldi G, Faustini SE, Richter AG, Shaheen SO et al. ( 2024 ) . Long-term air pollution exposure and risk of SARS-CoV-2 infection: A UK-wide cohort study . Respiratory Medicine vol. 224 ,

Vivaldi G, Pfeffer P, Talaei M, Basera J, Shaheen S, Martineau A ( 2023 ) . S18 Long-term symptom profiles after COVID-19 vs other acute respiratory infections: a population-based observational study . Conference: ‘Shake it off’ – Recovery from COVID-19a17 - a18 .

Hajmohammadi H, Talaei M, Fecht D, Wang W, Vivaldi G, Faustini S, Richter A, Shaheen S et al. ( 2023 ) . Long-term air pollution exposure and risk of SARS-CoV-2 infection: A UK-wide cohort study . Conference: Epidemiology

Vivaldi G, Pfeffer P, Talaei M, Basera TJ, Shaheen S, Martineau A ( 2023 ) . Long-term symptom profiles after COVID-19 versus other acute respiratory infections: an analysis of data from the COVIDENCE UK study . EClinicalMedicine

Zheng B, Vivaldi G, Daines L, Leavy OC, Richardson M, Elneima O, McAuley HJC, Shikotra A et al. ( 2023 ) . Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls . The Lancet Regional Health - Europe vol. 29 ,

Holt H, Jolliffe DA, Talaei M, Faustini S, Vivaldi G, Greenig M, Richter AG, Lyons RA et al. ( 2023 ) . Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination . npj Vaccines vol. 8 , ( 1 )

Vivaldi G, Jolliffe DA, Faustini S, Holt H, Talaei M, Tydeman F, Richter AG, Shaheen SO et al. ( 2022 ) . Correlation between post-vaccination titres of anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection in 7530 UK adults . Conference: 06.01 - Epidemiology

Jolliffe DA, Faustini SE, Holt H, Talaei M, Vivaldi G, Richter AG, Shaheen SO, Martineau AR ( 2022 ) . Determinants of antibody responses to primary courses and booster doses of SARS-CoV-2 vaccines in 9,101 UK adults . Conference: 10.01 - Respiratory infections and bronchiectasis

Talaei Pashiri M, Faustini S, Holt H, Jolliffe DA, Vivaldi G, G Richter A, Shaheen SO, Martineau AR ( 2022 ) . Determinants of pre-vaccination SARS-CoV-2 seropositivity: a population-based longitudinal study (COVIDENCE UK) . Conference: 06.01 - Epidemiology

Vivaldi G, Jolliffe DA, Holt H, Talaei M, Tydeman F, Shaheen SO, Martineau AR ( 2022 ) . Risk factors for breakthrough COVID-19 in 15,804 UK adults after primary and booster doses of SARS-CoV-2 vaccines . Conference: 06.01 - Epidemiology

Tydeman F, Pfeffer PE, Vivaldi G, Holt H, Talaei M, Jolliffe D, Davies G, Lyons RA et al. ( 2022 ) . Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK) . Thorax vol. 78 , ( 8 ) 752 - 759 .

Vivaldi G, Jolliffe D, Holt H, Talaei M, Tydeman F, Shaheen S, Martineau A ( 2022 ) . S37 Risk factors for breakthrough COVID-19 in 14,713 UK adults after primary and booster doses of SARS-CoV-2 vaccines . Conference: ‘Outbreak!’ – COVID-19 epidemiologya25.2 - a2a26 .

Holt H, Relton C, Talaei M, Symons J, Davies MR, Jolliffe DA, Vivaldi G, Tydeman F et al. ( 2022 ) . Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK) . International Journal of Epidemiology vol. 52 , ( 1 )

Jolliffe DA, Faustini SE, Holt H, Perdek N, Maltby S, Talaei M, Greenig M, Vivaldi G et al. ( 2022 ) . Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK) . Vaccines vol. 10 , ( 10 ) 1601 - 1601 .

Vivaldi G, Jolliffe D, Tydeman F, Talaei M, Davies GA, Lyons RA, GRIFFITHS CJ, Kee F et al. ( 2022 ) . Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT1262b2 and after booster vaccination with BNT1262b2 or mRNA-1273: a population-based cohort study (COVIDENCE UK) . The Lancet Regional Health Europe

Jolliffe DA, Vivaldi G, Chambers ES, Cai W, Li W, Faustini SE, Gibbons JM, Pade C et al. ( 2022 ) . Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial . Nutrients vol. 14 , ( 18 )

Jolliffe DA, Holt H, Greenig M, Talaei M, Perdek N, Pfeffer P, Vivaldi G, Maltby S et al. ( 2022 ) . Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: Phase 3 randomised controlled trial (CORONAVIT) . The BMJ

Vivaldi G, Jolliffe DA, Faustini S, Shields AM, Holt H, Perdek N, Talaei M, Tydeman F et al. ( 2022 ) . Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study . The Journal of Infectious Diseases vol. 226 , ( 11 ) 1903 - 1908 .

Talaei M, Faustini S, Holt H, Jolliffe DA, Vivaldi G, Greenig M, Perdek N, Maltby S et al. ( 2022 ) . Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK) . BMC Medicine vol. 20 , ( 1 )